Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Gish

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Viral Hepatitis|December 15, 2010
Is chronic hepatitis B being undertreated in the United States?C Cohen, S D Holmberg, B J McMahon, et al.
Pediatric Research|June 15, 1999
GB virus C (GBV-C/HGV) and E2 antibodies in children preliver and postliver transplantO Elkayam, H M Hassoba, L D Ferrell, et al.
Hepatology (Baltimore, Md.)|January 1, 1996
Ganciclovir treatment of hepatitis B virus infection in liver transplant recipientsR G Gish, J Y Lau, L Brooks, et al.
Digestive Diseases and Sciences|December 1, 1995
Significance of hepatic expression of hepatitis C viral antigens in chronic hepatitis CR P González-Peralta, J W Fang, G L Davis, et al.
Journal of Viral Hepatitis|May 22, 2009
Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside-naïve HBeAg-positive patients with chronic hepatitis BT-T Chang, Y-C Chao, V V Gorbakov, et al.
Viral Immunology|January 1, 1993
Variation in antibody reactivity to the hepatitis C virus by comparative immunoscreening and enzyme immunoassayR G Gish, M T Warmerdam, J B Zeldis, et al.
The Journal of Infectious Diseases|February 1, 1995
Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United StatesJ Y Lau, M Mizokami, J A Kolberg, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
Dose range study of pharmacokinetics, safety, and preliminary antiviral activity of emtricitabine in adults with hepatitis B virus infectionR G Gish, N W Y Leung, T L Wright, et al.
Journal of Viral Hepatitis|September 29, 2016
Community-based real-world treatment outcomes of sofosbuvir/ledipasvir in Asians with chronic hepatitis C virus genotype 6 in the United StatesR J Wong, M T Nguyen, H N Trinh, et al.
Journal of Viral Hepatitis|June 6, 2017
Hepatitis B surface antigen loss and sustained viral suppression in Asian chronic hepatitis B patients: A community-based real-world studyR J Wong, M T Nguyen, H N Trinh, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Viral Hepatitis|December 15, 2010
Is chronic hepatitis B being undertreated in the United States?C Cohen, S D Holmberg, B J McMahon, et al.
Pediatric Research|June 15, 1999
GB virus C (GBV-C/HGV) and E2 antibodies in children preliver and postliver transplantO Elkayam, H M Hassoba, L D Ferrell, et al.
Hepatology (Baltimore, Md.)|January 1, 1996
Ganciclovir treatment of hepatitis B virus infection in liver transplant recipientsR G Gish, J Y Lau, L Brooks, et al.
Digestive Diseases and Sciences|December 1, 1995
Significance of hepatic expression of hepatitis C viral antigens in chronic hepatitis CR P González-Peralta, J W Fang, G L Davis, et al.
Journal of Viral Hepatitis|May 22, 2009
Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside-naïve HBeAg-positive patients with chronic hepatitis BT-T Chang, Y-C Chao, V V Gorbakov, et al.
Viral Immunology|January 1, 1993
Variation in antibody reactivity to the hepatitis C virus by comparative immunoscreening and enzyme immunoassayR G Gish, M T Warmerdam, J B Zeldis, et al.
The Journal of Infectious Diseases|February 1, 1995
Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United StatesJ Y Lau, M Mizokami, J A Kolberg, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
Dose range study of pharmacokinetics, safety, and preliminary antiviral activity of emtricitabine in adults with hepatitis B virus infectionR G Gish, N W Y Leung, T L Wright, et al.
Journal of Viral Hepatitis|September 29, 2016
Community-based real-world treatment outcomes of sofosbuvir/ledipasvir in Asians with chronic hepatitis C virus genotype 6 in the United StatesR J Wong, M T Nguyen, H N Trinh, et al.
Journal of Viral Hepatitis|June 6, 2017
Hepatitis B surface antigen loss and sustained viral suppression in Asian chronic hepatitis B patients: A community-based real-world studyR J Wong, M T Nguyen, H N Trinh, et al.
Pageof 3